** Shares of major U.S. drugmakers rise between 2% and 3% in early trading amid a broader market selloff
** Johnson & Johnson JNJ.N rises 2.4% to $159.07, Merck MRK.N 2.2% to $88.33, AbbVie ABBV.N 2.5% to $210.28, Amgen AMGN.O 2.3% to $312.23
** The pharma sector ducked U.S. President Donald Trump's sweeping tariffs announced on Wednesday for now
** The news came as "a big positive to the (pharma) sector that has been under pressure from this for the last two weeks," UBS analysts said, adding that AbbVie and Merck, with significant ex-U.S. manufacturing, came out as "big winners"
** However, the administration's call for "robust and resilient domestic manufacturing" in the sector, suggests that it remained on its radar - UBS
** Up to last close, JNJ up 7.4%, AMGN up 17.3%, MRK down ~13%, ABBV up 15.5% so far this year
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。